As for respiratory viruses, elevated IgA serum levels have been shown to correlate with influenza vaccine efficacy (73, 74) and SARS-CoV-2 neutralization has been reported to correlate more closely with serum IgA than IgM or IgG during the first weeks after symptom onset (75). The gene discussed is CD79A; the disease is influenza.